BEKSAÇ, M. Et Al. 2011. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. EUROPEAN JOURNAL OF HAEMATOLOGY , vol.86, no.1 , 16-22.

BEKSAÇ, M., HAZNEDAR, R., Firatli-Tuglular, T., Ozdogu, H., Aydogdu, I., Konuk, N., ... Sucak, G.(2011). Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. EUROPEAN JOURNAL OF HAEMATOLOGY , vol.86, no.1, 16-22.

BEKSAÇ, MERAL Et Al. "Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group," EUROPEAN JOURNAL OF HAEMATOLOGY , vol.86, no.1, 16-22, 2011

BEKSAÇ, MERAL Et Al. "Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group." EUROPEAN JOURNAL OF HAEMATOLOGY , vol.86, no.1, pp.16-22, 2011

BEKSAÇ, M. Et Al. (2011) . "Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group." EUROPEAN JOURNAL OF HAEMATOLOGY , vol.86, no.1, pp.16-22.

@article{article, author={MERAL BEKSAÇ Et Al. }, title={Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group}, journal={EUROPEAN JOURNAL OF HAEMATOLOGY}, year=2011, pages={16-22} }